NATCO Pharma Limited announces the launch of additional strengths for the generic version of Revlimid (lenalidomide capsules), in 2.5 mg, and 20 mg strengths, in the United States, via an exchange filing.
The launch is through its marketing partner Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd.
With this launch the companies made available all the strengths of lenalidomide in the US market.
Lenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma.
Forest Land Scam: ED Attaches Assets Of BJP Leader Janardan Mahtre And His infrastructure Firm
US Fed Meeting: Jereome Powell Led US Federal Reserve Keeps Interest Rates 'Unchanged' For Fourth Time
Former Kannauj Lok Sabha Candidate Purushottam Tiwari Joins RLD With Hundreds Of Supporters In Lucknow
Bulandshahr Tragedy: Five Family Members Burned Alive In Car Crash, One Survivor Battles Injuries
